6:12 PM
 | 
Aug 01, 2014
 |  BC Extra  |  Company News

FDA approves Boehringer's Jardiance

FDA approved Jardiance empagliflozin from Boehringer Ingelheim GmbH (Ingelheim, Germany) to treat Type II diabetes. The company said it plans...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >